Development of anti-fungal pesticides from protein kinase inhibitor-based anticancer agents

Eur J Med Chem. 2018 Mar 25:148:349-358. doi: 10.1016/j.ejmech.2018.02.040. Epub 2018 Feb 15.

Abstract

Repurposing the novel p21-activated protein kinase inhibitor compound 15 identified its antifungal activity against five selected species of phytopathogenic fungi. Lead optimization based on its structure gave rise to a focused library of 20 derivatives, among which compound 3c demonstrated increased activity over compound 15 and even comparable to that of some commercialized fungicides in the market including carbendazim, tebuconazole, and pyraclostrobin. This study showed that p21-activated protein kinase inhibitor compound 15 was able to serve as a molecular platform to develop effective fungicides against fungal phytopathogens and indicate that screening existing protein kinase inhibitors might be an effective way to identify lead compounds for antifungal pesticides development.

Keywords: Antifungal agrochemical; Drug-repurposing discovery; Lead optimization; Protein kinase inhibitor.

MeSH terms

  • Antifungal Agents / chemistry*
  • Antineoplastic Agents
  • Drug Repositioning / methods*
  • Humans
  • Molecular Structure
  • Protein Kinase Inhibitors / pharmacology*
  • Small Molecule Libraries
  • Structure-Activity Relationship
  • p21-Activated Kinases / antagonists & inhibitors

Substances

  • Antifungal Agents
  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Small Molecule Libraries
  • p21-Activated Kinases